News

Indian Pharma Grows At Mere 1% In Sept Quarter, Recovery From Gst Disruption Slow

In the second quarter ended September the IPM grew 1 percent versus 14 percent in the same period previous year. Second quarter generally happens to be a good quarter for Indian drug market.

Indian pharmaceutical market (IPM) continued to be sluggish even in September month as the recovery from the supply chain disruption caused due to GST rollout in July seems to be a protracted one.

The industry grew at 2.8 percent in September with sales worth Rs ... Read More

Indian Pharma Grows At Mere 1% In Sept Quarter, Recovery From Gst Disruption Slow 14-Oct-2017

*why Online Pharmacies In India Not Able To Survive ? Regulations Or Incorrect Process* ?

In the last couple of years (2014-2016), many Online Pharmacies has started, some of them got funding as well, as large as USD 60 million. But, what we could see is, many of them are suffering drastically because of their cash burn in terms of discounts and heavy marketing, and not being able to figure out a way for break-even. Some of the funded startups have also shut down their operations in most regions, and others are trying to raise fresh round of funds for survival.

Read More

*why Online Pharmacies In India Not Able To Survive ? Regulations Or Incorrect Process* ? 14-Oct-2017

Health Ministry Issues Draft Rules To Facilitate Sales Of Drugs Online

The Union ministry of health and family welfare has issued draft of the Drugs (Sale and Distribution) Rules, 2017 aiming at removing ambiguity on regulations to facilitate sales of drugs online.

The ministry issued the draft rules in exercise of the powers conferred by section 12 and section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940) in supersession of Part VI, Schedule N, Form 19, Form 19A, Form 20, Form 20A, Form 20 B, Form 21, Form 21A, Form 21B, Form ... Read More

Health Ministry Issues Draft Rules To Facilitate Sales Of Drugs Online 06-Oct-2017

I-t Probes Pharma Company’s Funding Of Doctors

The income tax (I-T) investigation wing claims to have unearthed a nexus between a leading pharmaceutical company and doctors and evidence showing payments running into crores to the latter for prescribing the company’s medicines.

MUMBAI: The income tax (I-T) investigation wing claims to have unearthed a nexus between... Read More

I-t Probes Pharma Company’s Funding Of Doctors 03-Oct-2017

Is Price Control The Solution To The Ills Of The Healthcare Industry?

A study by IMS Health published in 2015 showed that price control on drugs has an adverse effect on drug availability as pharma companies may have to exit a therapeutic category due to low profits.

Amir Ullah Khan

Out-of-pocket expenses have always been high in the healthcare sector in India. The poor pay nearly two thirds of healthcare costs out of pocket, and incur substantial debt while doing so. Also, of the health expenditure nearly 70 percent is for bu... Read More

Is Price Control The Solution To The Ills Of The Healthcare Industry? 02-Oct-2017

How Online Pharmacies Are Now Rushing To Pace Up Growth

Dt.17-092017  (Source ET Healthworld)

The government is at last ready to acknowledge the online pharmacy sector and, at least in principle, agreed to give a serious hearing to their key demands.

Pradeep Dadha is a busy man these days, re-laying the platform of his epharmacy, Read More

How Online Pharmacies Are Now Rushing To Pace Up Growth 17-Sep-2017

Cadila Healthcare, Torrent Pharma Eyeing Potential Merger

 

"More clarity on the proposed structure, valuations can be expected in the next six months," a source said adding that the merger may or may not fructify.

The domestic pharmaceuticals sector may be set for a shake-up as Ahmedabad headquartered Cadila Healthcare led by Read More

Cadila Healthcare, Torrent Pharma Eyeing Potential Merger 23-Aug-2017

How Billionaire Father-son Duo Turned Family Firm Into World Beater

Dt.11/08/2017 ET Healthworld

Last month Pankaj Patel announced his more than 20-years running the company were over.

By Ari Altstedter

If the stock market is any guide, Sharvil Patel has just inherited one of the top Read More

How Billionaire Father-son Duo Turned Family Firm Into World Beater 11-Aug-2017

India's Top 100 Pharma Cos Post Single Digit Growth In Sales & Profit During 2016-17

India's top 100 pharma cos post single digit growth in sales & profit during 2016-17

Sanjay Pingle, Mumbai
Wednesday, August 09, 2017, 08:00 Hrs  [IST]
 

The financial p... Read More India's Top 100 Pharma Cos Post Single Digit Growth In Sales & Profit During 2016-17 09-Aug-2017

Biocon Developing 10 Biosimilars That Collectively Target Global Market Opportunity Of Over $60 Billion: Kiran Mazumdar-shaw

Dt.08/08/2017 ET Healthworld

By Priyanka V Gupta

New Delhi: India’s biopharmaceutical company Biocon, which ranks among top three biosimilar global players for insulin, has multiple successes in its container since its inception. So far, Bio... Read More

Biocon Developing 10 Biosimilars That Collectively Target Global Market Opportunity Of Over $60 Billion: Kiran Mazumdar-shaw 08-Aug-2017

Roche, Emcure May End Pact To Make 2 Blockbuster Drugs

Dt.25-07-2017 ET Healthworld

MUMBAI: A joint venture between Swiss drug maker Roche and India’s EmcurePharmaceuticals to manufacture and distribute two blockbuster drugs may be coming apart five years after it was formed, ET has learnt. Leading drug distributors told ... Read More

Roche, Emcure May End Pact To Make 2 Blockbuster Drugs 25-Jul-2017

No More Underreporting Of Infections: Hospitals To Upload Patient Details Online

Dt-21-07-2017 Source-ET Healthworld

CHENNAI: Come August, civic bodies in the state can no longer throw a cloak over an outbreak as the government readies a software that will require hospitals to upload patients’ details online.

As part of the initiative, hospitals in 12 corporations will have to notify the government, if patients walk in complaining of fever, diarrh... Read More

No More Underreporting Of Infections: Hospitals To Upload Patient Details Online 21-Jul-2017

'centre To Set Up E-portal To Regulate Online Sale Of Drugs'

Dt.21/07/2017  ET HEALTHWORLD

Mumbai: All manufacturers, distributors and retailers, interested in selling drugs and medicines online will have to register themselves on an e-portal to be set up soon by the Centre, the Bombay High Court was told on Thursday.

Read More

'centre To Set Up E-portal To Regulate Online Sale Of Drugs' 21-Jul-2017

Code To Ban Bribes From Companies To Doctors In Final Stages

Dt.15/07/2017 Economics Times

After a two-year delay, a mandatory marketing code for the pharmaceutical industry to stop the bribing of doctors and health professionals may soon come into force. The pharmaceuticals department (DoP) earlier this week sent the draft Essential Commodities (Control of Read More

Code To Ban Bribes From Companies To Doctors In Final Stages 15-Jul-2017

Nppa Gets Gst Ready; Releases Ceiling Price Of 761 Medicines

Dt.28/06/2017

New Delhi: Drug price regulator NPPA on Tuesday announced provisional ceiling prices of 761 medicines, including anti-cancer, HIVdiabetes and antibiotic, with a majority being reduced ahead of the Read More

Nppa Gets Gst Ready; Releases Ceiling Price Of 761 Medicines 28-Jun-2017

Lupin Founder And Chairman Desh Bandhu Gupta Passes Away

Dt.26/07/2017

NEW DELHI: Founder and Chairman of pharma major LupinDesh Bandhu Gupta passed away this morning in Mumbai. Gupta (79), founded Lupin in 1968 and created a global pharmaceutical major with a presence in over 100 countries. He is survi... Read More

Lupin Founder And Chairman Desh Bandhu Gupta Passes Away 27-Jun-2017

Jubilant Life Ties Up With Dutch Firm Barentz For Food & Nutrition Market

Noida-based pharmaceutical company Jubilant Life Sciences has entered into a strategic partnership with Barentz International, the Netherlands-based producer & distributor of high... Read More

Jubilant Life Ties Up With Dutch Firm Barentz For Food & Nutrition Market 23-Jun-2017

Astrazeneca Sells Antacid Brand Neksium To Pfizer India For Rs 75 Cr

AstraZeneca AB, Sweden, has sold its antacid brand Neksium to Pfizer Ltd, which als... Read More

Astrazeneca Sells Antacid Brand Neksium To Pfizer India For Rs 75 Cr 02-Jun-2017

Tampering With The Mrp Is A Serious Offence

Tampering with the MRP is a serious offence

As per the Legal Metrology Act, 2009 and the Legal Metrology (Packaged Commodities) Rules 2011 has notified MRP Hike, MRP Tampering, Missing MRP as an offence punishable with fine and also with imprisonment. However, if any default or discrepancy is noticed, the seller is liable for suitable action in terms of suspension and/or penalty from Paytm. Grounds for penalization could include:<... Read More

Tampering With The Mrp Is A Serious Offence 02-May-2017

*pci Set To Make Exit Exam Mandatory For New Pharmacy Diploma Pass Outs To Become Registered Pharmacists*

*PCI set to make exit exam mandatory for new pharmacy diploma pass outs to become registered pharmacists*
 

The Pharmacy Council of India (PCI) is all set to make exit examination mandatory for students passing out diploma in pharmacy from academic year *2017-18* to become eligible for registration with state pharmacy councils.

Read More

*pci Set To Make Exit Exam Mandatory For New Pharmacy Diploma Pass Outs To Become Registered Pharmacists* 02-May-2017

Delhi Hc Bars Cipla From Selling Novartis’ Respiratory Drug

Dt.24/04/2017

The Delhi high court on Thursday barred Cipla Ltd from selling copies of Novartis AG’s respiratory drug Onbrez in India, upholding the patents held by the swiss drug maker. “We would not like to interfere with the order of the single judge citing patent infringement by Cipla. Accordingly, the appeal is dismissed,” said Justice Badar Ahmed Durrez. The court was hearing an appeal by Cipla ag... Read More

Delhi Hc Bars Cipla From Selling Novartis’ Respiratory Drug 24-Apr-2017

Japanese Companies Make Cautious Return To Indian Pharma Market

Dt.24/04/2017

After burning their fingers more than once in India with troubled acquisitions, Japanese drug makers are back in this market, this time through the age-old route of product launches. Japanese companies received the highest number of drug approvals from the Drug Controller General of India in 2016, beating their American and Swiss counterparts. Out of the 20 approvals that came in the past year, five went to four Japanese companies: Eisai, Tak... Read More

Japanese Companies Make Cautious Return To Indian Pharma Market 24-Apr-2017

Cdsco Finds D Cold Total, Combiflam To Be Substandard

Dt.24/04/2017

The Central Drugs Standard Control Organization (CDSCO) has found popular painkiller Combiflam and cold medicine D Cold Total, manufactured and sold by Sanofi India and Reckitt Benckiser Healthcare India, respectively, to be substandard in its tests done last month. Moreover, Cipla’s Oflox-100 DT tablets and Theo Asthalin tablets, as well as Cadila’s Cadilose solution have also been found to be substandard. In total, the CDSCO has issued a drug alert for 60 m... Read More

Cdsco Finds D Cold Total, Combiflam To Be Substandard 24-Apr-2017

Delhi Hc Quashes Government Ban On Fdc Drugs

Dt.01/12/2016

Delhi HC quashes government ban on FDC drugs

The verdict is a major relief for the pharmaceutical sector



The Delhi high court reserved its verdict in the case on 2 June. Photo: Mint
New Delhi: In a major relief to the pharmaceutical sector, the Delhi high court on Thursday quashed a government-imposed ban on fixed dose combination (FDC) drugs.

The cases—filed by... Read More

Delhi Hc Quashes Government Ban On Fdc Drugs 01-Dec-2016

Government May Disband National Pharmaceutical Pricing Authority

Via The Economic Times | Yogima Sharma, New Delhi | Nov 03, 2016

 

In a major overhaul of the country's drug policy, the government is likely to soon disband the National Pharmaceutical Pricing Authority (NPPA) in its present form and assume the power to set prices of essential medicines, as it see... Read More

Government May Disband National Pharmaceutical Pricing Authority 03-Nov-2016

Sun Pharma Among Bidders For Bayer's Dermatology Brands (ims)

Teva, Perrigo, Allergan and Almirall with Galderma also said to be in the race

Sun Pharmaceuticals is among several pharmaceutical companies and private equity investors that have reportedly expressed preliminary interest in buying the dermatology business of Bayer. The German pharmaceutical and agri-chemicals giant is working with JP Morgan Chase and the deal is expected to fetch $1.1 billion, a Bloomberg report said.... Read More

Sun Pharma Among Bidders For Bayer's Dermatology Brands (ims) 23-Sep-2016

Pfizer Plans To Bring More Global Drugs To India (ndtv)

New Delhi: Pharmaceutical giant Pfizer plans to introduce more drugs from its global portfolio in India, including injectables from the stable of Hospira which it had acquired last year.

Although the company sells most of its top 20 global products in India, it is looking to bring in a couple of drugs, the patents of which have expired, to the domestic market.

"Except for a couple of CNS (central nervous system) products and one pain product... Read More

Pfizer Plans To Bring More Global Drugs To India (ndtv) 08-Sep-2016

Authorised Stockist For

Abbott ADCOCK ALEMBIC alkem alcon Aristo Astrazeneca Bayert BHARAT SERUM biochem Biocon Biogen Biotest besins Blue Cross boehringer Bristol Cadila CelonLabs Cipla clder EMCURE FDC FEERING Fresenius GENNOVA Genzyme Gland Glenmark GSK HETERO Himalaya Intas Larenon LILLY LUNDBECK MANKIND merck MODIMUNDI msd MYLAN Natco neon NOUVEAU Novartis Novo NUTRICIA Panacea Phzer Piramal Reliance Reddys roche rusan steadfast Samarth Sanafi strids sarabhai Shreya Sun SVIZERA Sydus Torrent TROIKAA united VIRCHAOW Wallace Wochardt WYETH Zuventus view all companies